CS241074B2 - Method of thiazolidine derivatives preparation - Google Patents

Method of thiazolidine derivatives preparation Download PDF

Info

Publication number
CS241074B2
CS241074B2 CS841885A CS188584A CS241074B2 CS 241074 B2 CS241074 B2 CS 241074B2 CS 841885 A CS841885 A CS 841885A CS 188584 A CS188584 A CS 188584A CS 241074 B2 CS241074 B2 CS 241074B2
Authority
CS
Czechoslovakia
Prior art keywords
ppm
compound
formula
group
indomethacin
Prior art date
Application number
CS841885A
Other languages
Czech (cs)
English (en)
Other versions
CS188584A2 (en
Inventor
Elemer Ezer
Kalman Harsanyi
Gyoergy Domany
Laszlo Szporny
Judit Matuz
Bela Hegedues
Katalin Pallagi
Isvan Szabadkai
Peter Tetenyi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to CS846479A priority Critical patent/CS241096B2/cs
Publication of CS188584A2 publication Critical patent/CS188584A2/cs
Publication of CS241074B2 publication Critical patent/CS241074B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS841885A 1983-03-16 1984-03-15 Method of thiazolidine derivatives preparation CS241074B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS846479A CS241096B2 (cs) 1983-03-16 1984-03-15 Způsob přípravy derivátů thiazolidinu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU83888A HU188852B (en) 1983-03-16 1983-03-16 Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer

Publications (2)

Publication Number Publication Date
CS188584A2 CS188584A2 (en) 1985-06-13
CS241074B2 true CS241074B2 (en) 1986-03-13

Family

ID=10951891

Family Applications (1)

Application Number Title Priority Date Filing Date
CS841885A CS241074B2 (en) 1983-03-16 1984-03-15 Method of thiazolidine derivatives preparation

Country Status (32)

Country Link
US (1) US4616025A (fi)
JP (1) JPS59196877A (fi)
KR (1) KR840008001A (fi)
AT (1) AT383596B (fi)
AU (1) AU559753B2 (fi)
BE (1) BE899132A (fi)
CA (1) CA1273933A (fi)
CH (1) CH660592A5 (fi)
CS (1) CS241074B2 (fi)
DD (1) DD216929A5 (fi)
DE (1) DE3409801A1 (fi)
DK (1) DK143284A (fi)
ES (2) ES530738A0 (fi)
FI (1) FI79843C (fi)
FR (1) FR2542740B1 (fi)
GB (1) GB2140412B (fi)
GR (1) GR81883B (fi)
HU (1) HU188852B (fi)
IE (1) IE57101B1 (fi)
IL (1) IL71249A (fi)
IN (1) IN157738B (fi)
IT (1) IT1196048B (fi)
LU (1) LU85248A1 (fi)
NL (1) NL8400817A (fi)
NO (1) NO162858C (fi)
NZ (1) NZ207516A (fi)
PL (2) PL142909B1 (fi)
PT (1) PT78260B (fi)
SE (1) SE455945B (fi)
SU (2) SU1240355A3 (fi)
YU (1) YU47384A (fi)
ZA (1) ZA841938B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051184A (ja) * 1983-08-30 1985-03-22 Fujimoto Seiyaku Kk Ν−シアノイミノチアゾリジン誘導体およびその製造法
US5204360A (en) * 1985-02-04 1993-04-20 Nihon Bayer Agrochem K.K. Heterocyclic compounds
US5001138B1 (en) * 1985-02-04 1998-01-20 Bayer Agrochem Kk Heterocyclic compounds
JPH066585B2 (ja) * 1985-02-04 1994-01-26 日本バイエルアグロケム株式会社 ニトロメチレン誘導体、その製法及び殺虫剤
EP0192060B1 (de) * 1985-02-04 1991-09-18 Nihon Bayer Agrochem K.K. Heterocyclische Verbindungen
JPH0730070B2 (ja) * 1985-10-03 1995-04-05 日本バイエルアグロケム株式会社 新規複素環式化合物
JPH0649699B2 (ja) * 1985-02-04 1994-06-29 日本バイエルアグロケム株式会社 ニトロメチレン誘導体、その製法及び殺虫剤
USRE39130E1 (en) 1986-03-07 2006-06-13 Bayer Cropscience K.K. Heterocyclic compounds
JPH0717621B2 (ja) * 1986-03-07 1995-03-01 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
JP2607369B2 (ja) * 1987-02-20 1997-05-07 興和株式会社 新規な複素環化合物
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
EP0478694B1 (en) * 1989-06-21 1997-01-15 The Trustees Of The University Of Pennsylvania use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT
HU207047B (en) * 1989-11-07 1993-03-01 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives and pharmaceutical copositions comprising same
CA2063865A1 (en) * 1992-03-24 1993-09-25 Karoly Lempert 2-(substituted imino)-thiazolidines and process for the preparation thereof
JP2721805B2 (ja) * 1994-07-22 1998-03-04 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
DE4427569A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Verfahren zur Herstellung von Cyanimino-1,3-thiazolidin
DE4427539A1 (de) * 1994-08-04 1996-02-08 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von 2-Cyaniminothiazolidin
DE19904310A1 (de) * 1999-01-28 2000-08-03 Bayer Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CA2366260A1 (en) * 1999-03-05 2000-09-14 Masahiro Imoto Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors
NZ529615A (en) * 2001-05-25 2005-07-29 Valley Forge Pharmaceuticals Pirenzepine ophthalmic gel
OA12963A (en) * 2002-11-22 2006-10-13 Smithkline Beecham Corp Novel chemical compounds.
WO2004089927A1 (en) * 2003-04-07 2004-10-21 Cortical Pty Ltd Novel methods for the treatment of inflammatory diseases
WO2010001922A1 (ja) * 2008-07-01 2010-01-07 株式会社クレハ 新規イミノ誘導体とその製造法、並びにこれを含有する殺虫剤
ES2556470T3 (es) * 2011-09-02 2016-01-18 Bayer Intellectual Property Gmbh Procedimiento para preparar [3-[(6-cloro-3-piridinil)metil]-2-tiazolidiniliden]cianamida

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264316A (en) * 1963-09-18 1966-08-02 Res Lab Dr C Janssen N V Certain 2-acylimino-3-substitutedthiazoline-4 compounds
DE2205745A1 (de) * 1972-02-08 1973-08-23 Thomae Gmbh Dr K Neue durch den n-cyaniminorest substituierten heterocyclen und verfahren zu ihrer herstellung
US4006156A (en) * 1975-06-27 1977-02-01 Shell Oil Company 3-Alkyl-2-(nitromethylene) thiazolidine
NL7704322A (nl) * 1976-05-03 1977-11-07 Merck & Co Inc Werkwijze voor het bereiden van 2-iminothiazo- lidinen en -thiazolinen.
JPS57171986A (en) * 1981-04-14 1982-10-22 Taiho Yakuhin Kogyo Kk Heterocylic ring compound containing sulfur
JPS5823682A (ja) * 1981-08-03 1983-02-12 Santen Pharmaceut Co Ltd 複素五員環化合物
DE3133918A1 (de) * 1981-08-27 1983-03-17 Bayer Ag, 5090 Leverkusen 2-arylhydrazino-2-thiazoline, acylderivate derselben, 2-arylazo-2-thiazoline, herstellungsverfahren und ihre verwendung zur bekaempfung von ekto- und endoparasiten
JPS58222886A (ja) * 1982-06-19 1983-12-24 Ricoh Co Ltd 感熱記録シ−ト
JPS5933267A (ja) * 1982-08-19 1984-02-23 Fujimoto Seiyaku Kk グアニジン誘導体およびその製造法

Also Published As

Publication number Publication date
FR2542740B1 (fr) 1987-02-20
PT78260B (en) 1986-04-30
PT78260A (en) 1984-04-01
FI79843C (fi) 1990-03-12
ES8604179A1 (es) 1986-01-16
CA1273933A (en) 1990-09-11
IN157738B (fi) 1986-05-31
FR2542740A1 (fr) 1984-09-21
DE3409801A1 (de) 1984-09-20
GB8406790D0 (en) 1984-04-18
KR840008001A (ko) 1984-12-12
DD216929A5 (de) 1985-01-02
PL142909B1 (en) 1987-12-31
NZ207516A (en) 1986-06-11
ATA88284A (de) 1986-12-15
US4616025A (en) 1986-10-07
IE57101B1 (en) 1992-04-22
IT1196048B (it) 1988-11-10
GB2140412A (en) 1984-11-28
SU1240355A3 (ru) 1986-06-23
CH660592A5 (de) 1987-05-15
PL246683A1 (en) 1985-07-16
AU2583384A (en) 1984-09-20
IL71249A (en) 1987-02-27
IT8420057A0 (it) 1984-03-15
JPS59196877A (ja) 1984-11-08
DK143284A (da) 1984-09-17
PL252129A1 (en) 1985-11-19
SE455945B (sv) 1988-08-22
SU1240356A3 (ru) 1986-06-23
FI79843B (fi) 1989-11-30
ES544286A0 (es) 1986-01-16
HU188852B (en) 1986-05-28
NL8400817A (nl) 1984-10-16
GB2140412B (en) 1987-02-11
AT383596B (de) 1987-07-27
BE899132A (fr) 1984-09-12
AU559753B2 (en) 1987-03-19
CS188584A2 (en) 1985-06-13
LU85248A1 (fr) 1985-10-14
NO162858C (no) 1990-02-28
NO841002L (no) 1984-09-17
ZA841938B (en) 1985-05-29
GR81883B (fi) 1984-12-12
SE8401463D0 (sv) 1984-03-15
IE840655L (en) 1984-09-16
DK143284D0 (da) 1984-02-29
FI841066A0 (fi) 1984-03-16
ES8601170A1 (es) 1985-11-01
FI841066A (fi) 1984-09-17
IL71249A0 (en) 1984-06-29
YU47384A (fi) 1986-10-31
NO162858B (no) 1989-11-20
PL142749B1 (en) 1987-11-30
ES530738A0 (es) 1985-11-01
SE8401463L (sv) 1984-09-17

Similar Documents

Publication Publication Date Title
CS241074B2 (en) Method of thiazolidine derivatives preparation
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
KR100221041B1 (ko) 2-아릴티아졸 유도체 및 그의 약제학적 조성물
SU1400508A3 (ru) Способ получени производных арилтиазолов
GB1565966A (en) Aminoalkyl furan derivatives
DK162222B (da) 2-amino-5-hydroxy-4-methylpyrimidin-derivater og farmeceutiske praeparater indeholdende disse
JPH0233031B2 (fi)
US6380229B1 (en) 2-(N-cyanoimino)thiazolidin-4-one derivatives
RU2001911C1 (ru) Способ получени замещенных 1,2,3,4-тетрагидронафталинов или их фармацевтически приемлемых аддитивных солей кислоты
NZ188770A (en) Thiazolinylguanidine derivatives and pharmaceutical compositions
MXPA06004434A (es) Usos medicos novedosos de compuestos que muestran actividad antagonista cb1 y tratamiento de combinacion que involucra tales compuestos.
EP0259085B1 (en) 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
JPH0653748B2 (ja) １Ｈ，３Ｈ−ピロロ〔１，２−ｃ〕チアゾ−ル誘導体、その製造法およびそれを含有する組成物
JPS62265270A (ja) 新規イミダゾ−ル誘導体およびそれらを有効成分とする抗潰瘍剤
GB1598365A (en) Pharmaceutically active amines di-substituted by hetero cyclic groups
SU1346042A3 (ru) Способ получени производных 2-пиридин-тиола или их кислотно-аддитивных солей (его варианты)
JPH0533952B2 (fi)
CS241096B2 (cs) Způsob přípravy derivátů thiazolidinu
Shafik et al. Synthesis of novel 2-[2-(substituted amino) phenethyl]-1H-benzimidazoles; 3, 4-dihydro and 1, 2, 3, 4,-tetrahydropyrimido [1, 6-a]-benzimidazoles as potential antiulcer agents
JPH0572386B2 (fi)
JPH0680041B2 (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
SU1217258A3 (ru) Способ получени производных 2-гуанидино-4-гетероарилтиазола или их фармацевтически приемлемых кислотно-аддитивных солей
JPH11100373A (ja) 新規フェノチアジン誘導体及びその医薬
JPH034068B2 (fi)
JPS59193894A (ja) ベンゾ縮合複素環抗潰瘍剤